Panagiotis Konstantininopoulos
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Panagiotis Konstantininopoulos as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:29 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03675893 · RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial CancerDana-Farber Cancer Institute · recruiting · Endometrial Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:29 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- Local biochemical and morphological differences in human Achilles tendinopathy: a case control study.BMC Musculoskelet Disord · 201252 citationsRCR 2.4
- Six months versus nine months anti-tuberculous therapy for female genital tuberculosis: a randomized controlled trial.Eur J Obstet Gynecol Reprod Biol · 201634 citationsRCR 1.9
- Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.Stem Cells Transl Med · 202118 citationsRCR 1.1
- Patients' knowledge about medicines improves when provided with written compared to verbal information in their native language.PLoS One · 202217 citationsRCR 2.3
- Gastric Residual Volumes Versus Abdominal Girth Measurement in Assessment of Feed Tolerance in Preterm Neonates: A Randomized Controlled Trial.Adv Neonatal Care · 201816 citationsRCR 1.3
- 14 citationsRCR 3.1
- Treatment of tumor lysis syndrome in children with leukemia/lymphoma in resource-limited settings-Efficacy of a fixed low-dose rasburicase.Pediatr Hematol Oncol · 201713 citationsRCR 0.8
- Evaluation of the effectiveness of a custom-made toothbrush in maintaining oral hygiene and gingival health in cerebral palsy patients.Spec Care Dentist · 20189 citationsRCR 1.0
- Comparison of the effectiveness of DFDBA and T-PRF in the regeneration of intra-bony defects- A randomized split-mouth study.J Stomatol Oral Maxillofac Surg · 20249 citationsRCR 3.8
- Clinical and patient-reported outcomes of periodontal phenotype modification therapy using injectable platelet rich fibrin with microneedling and free gingival grafts: A prospective clinical trial.J Stomatol Oral Maxillofac Surg · 20248 citationsRCR 4.1